NCT03712241 is a Phase 1 clinical trial of K-285 in Healthy, sponsored by Kowa Research Institute, Inc..

Who is sponsoring NCT03712241?

NCT03712241 is sponsored by Kowa Research Institute, Inc..

What drugs are being tested in NCT03712241?

Interventions in NCT03712241: K-285, Indomethacin.

Is NCT03712241 still recruiting?

NCT03712241 is currently completed. Last updated 17 January 2019.

Last reviewed 2019-01-17 · How we verify

NCT03712241

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults

Completed Phase 1 Last updated 17 January 2019

What this trial tests

Phase 1 trial testing K-285 in Healthy in 15 participants. Completed in 6 January 2019.

Timeline

4 October 2018

Primary endpoint
6 January 2019

6 January 2019

Quick facts

Lead sponsor	Kowa Research Institute, Inc.
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	15
Start date	4 October 2018
Primary completion	6 January 2019
Estimated completion	6 January 2019
Sites	1 location across United States

Drugs / interventions tested

K-285 — full drug profile →
Indomethacin (INDOMETHACIN) — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Kowa Research Institute, Inc. — full company profile →

Who can join

Adults 18 to 45, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is to compare the PK parameters of multiple doses and applications of K-285 with a single dose of indomethacin capsule.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of K-285

Trials testing the same drug.

NCT04484428 — A Study to Evaluate the Efficacy and Safety of K-285 Compared With Menthol Gel for the Treatment of Delayed Onset Muscle · Phase 2 · terminated

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Kowa Research Institute, Inc. trials

Trials by the same sponsor.

NCT06525311 — A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis · Phase 1 · completed
NCT05826353 — A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexi · Phase 3 · completed
NCT05795699 — A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothel · Phase 3 · completed
NCT05722262 — Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration · Phase 1 · completed
NCT05327127 — Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis · Phase 2 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03712241 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kowa Research Institute, Inc.
Last refreshed: 17 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03712241.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing